CHF32.80
0.76% today
SIX Swiss Exchange, Jul 21, 09:41 am CET
ISIN
CH0038389992
Symbol
BION

BB Biotech Target price 2025 - Analyst rating & recommendation

BB Biotech Classifications & Recommendation:

Buy
90%
Hold
10%

BB Biotech Price Target

Target Price CHF67.41
Price CHF33.05
Potential
Number of Estimates 5
5 Analysts have issued a price target BB Biotech 2026 . The average BB Biotech target price is CHF67.41. This is higher than the current stock price. The highest price target is
CHF73.69 122.96%
register free of charge
, the lowest is .
A rating was issued by 10 analysts: 9 Analysts recommend BB Biotech to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BB Biotech stock has an average upside potential 2026 of . Most analysts recommend the BB Biotech stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million CHF 112.24 136.94
21,077.36% 22.01%
Net Margin 67.62% 159.01%
100.17% 135.14%

4 Analysts have issued a sales forecast BB Biotech 2025 . The average BB Biotech sales estimate is

CHF137m
Unlock
. This is
97.98% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF282m 307.59%
Unlock
, the lowest is
CHF0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CHF112m 21,077.36%
2025
CHF137m 22.01%
Unlock
2026
CHF156m 14.00%
Unlock

5 BB Biotech Analysts have issued a net profit forecast 2025. The average BB Biotech net profit estimate is

CHF218m
Unlock
. This is
151.17% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF322m 175.71%
Unlock
, the lowest is
CHF102m 123.93%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CHF75.9m 136.74%
2025
CHF218m 186.88%
Unlock
2026
CHF235m 8.03%
Unlock

Net Margin

2024 67.62% 100.17%
2025
159.01% 135.14%
Unlock
2026
150.68% 5.24%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share CHF 1.38 3.98
136.60% 188.41%
P/E 8.30
EV/Sales negative

5 Analysts have issued a BB Biotech forecast for earnings per share. The average BB Biotech EPS is

CHF3.98
Unlock
. This is
151.16% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
CHF5.89 175.71%
Unlock
, the lowest is
CHF1.86 123.91%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CHF1.38 136.60%
2025
CHF3.98 188.41%
Unlock
2026
CHF4.30 8.04%
Unlock

P/E ratio

Current -4.25 143.08%
2025
8.30 295.38%
Unlock
2026
7.68 7.47%
Unlock

Based on analysts' sales estimates for 2025, the BB Biotech stock is valued at an EV/Sales of

-2.09
Unlock
and an P/S ratio of
12.00
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -1.53 920.00%
2025
-2.09 49.54%
Unlock
2026
-1.84 12.28%
Unlock

P/S ratio

Current 26.37 203.95%
2025
12.00 49.49%
Unlock
2026
10.52 12.28%
Unlock

Current BB Biotech Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
ODDO BHF
Locked
Locked
Locked Apr 24 2025
PARETO SECURITIES AS
Locked
Locked
Locked Mar 02 2025
BAADER HELVEA EQUITY RESEARCH
Locked
Locked
Locked Feb 20 2025
ODDO BHF
Locked
Locked
Locked Jan 23 2025
BAADER HELVEA EQUITY RESEARCH
Locked
Locked
Locked Oct 24 2024
ODDO BHF
Locked
Locked
Locked Oct 24 2024
PARETO SECURITIES AS
Locked
Locked
Locked Aug 29 2024
Analyst Rating Date
Locked
ODDO BHF:
Locked
Locked
Apr 24 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
Mar 02 2025
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
Locked
Feb 20 2025
Locked
ODDO BHF:
Locked
Locked
Jan 23 2025
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
Locked
Oct 24 2024
Locked
ODDO BHF:
Locked
Locked
Oct 24 2024
Locked
PARETO SECURITIES AS:
Locked
Locked
Aug 29 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today